Breast Cancer Detection Kit, Device, and Method Patent Application
Summary
The USPTO has published a patent application (US20260085359A1) from TORAY INDUSTRIES, INC. for a breast cancer detection kit, device, and method. The application describes a kit or device comprising nucleic acids that specifically bind to a miRNA in a subject's sample, and a method for detecting breast cancer by measuring the miRNA in vitro.
What changed
The United States Patent and Trademark Office (USPTO) has published a patent application, US20260085359A1, filed by TORAY INDUSTRIES, INC. The application details a novel kit, device, and method for detecting breast cancer. The core of the invention lies in the use of specific nucleic acids designed to bind to a miRNA present in a biological sample, enabling in vitro detection of the cancer.
This publication represents a new patent application and does not impose immediate regulatory obligations. However, it signifies potential future intellectual property in the field of cancer diagnostics. Companies involved in developing or manufacturing diagnostic kits, medical devices, or pharmaceutical products related to breast cancer detection should be aware of this filing as it may impact future product development, licensing, or competitive landscape.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
BREAST CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD
Application US20260085359A1 Kind: A1 Mar 26, 2026
Assignee
TORAY INDUSTRIES, INC.
Inventors
Satoshi KONDOU, Hitoshi NOBUMASA, Satoko KOZONO, Hiroko SUDO, Junpei KAWAUCHI, Takahiro OCHIYA, Nobuyoshi KOSAKA, Makiko ONO, Kenji TAMURA
Abstract
It is intended to provide a kit or a device for the detection of breast cancer and a method for detecting breast cancer. The present invention provides a kit or a device for the detection of breast cancer, comprising nucleic acid(s) capable of specifically binding to a miRNA in a sample of a subject, and a method for detecting breast cancer, comprising measuring the miRNA in vitro.
CPC Classifications
C12Q 1/6886 C12M 1/00 C12Q 1/68 C12N 15/09 C12Q 2600/158 C12Q 2600/16 C12Q 2600/178
Filing Date
2025-07-11
Application No.
19266819
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.